Additional Benzene Ring Containing Patents (Class 514/736)
  • Patent number: 6103753
    Abstract: An intimal thickening inhibitory agent comprising, as an active ingredient, a compound represented by formula (1): ##STR1## wherein X represents an oxygen atom or a group of formula (2): ##STR2## wherein n represents an integer of from 0 to 2, R.sub.1 represents a hydrogen atom or an acyl group; R.sub.2 represents a hydrogen atom, a lower alkyl group or a lower alkenyl group; R.sub.3 represents a lower alkyl group; and R.sub.4, R.sub.5, and R.sub.6, which may be the same or different, each represent a hydrogen atom or a substituted or unsubstituted alkyl group; or R.sub.3 and R.sub.4 may be taken together to form a 5-membered ring; or R.sub.5 and R.sub.6 may be taken together to form a cycloalkyl group; provided that R.sub.6 is nil when R.sub.3 and R.sub.4 are taken together to form benzofuran or benzo[b]thiophene.
    Type: Grant
    Filed: May 6, 1998
    Date of Patent: August 15, 2000
    Assignee: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Osamu Cynshi, Reiko Sekimori, Yoshiaki Kato
  • Patent number: 6103768
    Abstract: The invention described here concerns the unique utility of fatty acids and their derivatives to eradicate existing fungal and bacterial infections in plants. Also, described herein are combination treatments whereby fatty acids are used to enhance or augment the activity of fungicides, bactericides, and biological control agents.
    Type: Grant
    Filed: September 8, 1997
    Date of Patent: August 15, 2000
    Assignee: Mycogen Corporation
    Inventors: Steven D. Savage, Steven L. Evans, Robert A. Haygood, Paul S. Zorner, Keith Jones
  • Patent number: 6080791
    Abstract: A method of preventing and treating a viral condition caused by an enveloped virus is described, comprising using a therapeutically effective amount of a compound selected from the group consisting of a substituted hydroquinone and the corresponding benzoquinone, wherein said hydroquinone comprises a 2-R.sup.1, 3-R.sup.2 -1,4-hydroquinone where at least one of R.sup.1 and R.sup.2 include a carbon linkage to the benzene ring of the hydroquinone. Particularly useful compounds include 5,8-dihydro-5,8-methano-1,4-naphthalenediol, 1,4-naphthoquinone, 3', 6'-dihydroxybenzo-norbornane, tert-butylhydroquinone, other diols, e.g. 1,5-naphthalenediol, and alkylated diols, e.g. 4-methoxy-1-naphthol.
    Type: Grant
    Filed: July 24, 1992
    Date of Patent: June 27, 2000
    Assignees: Seres Laboratories, Inc., University of California
    Inventors: Dale L. Bodian, Judith M. White, Irwin D. Kuntz, Jay F. Stearns, R. Bryan Yamasaki
  • Patent number: 6060500
    Abstract: This invention relates to a method for inhibiting bome resorption in a patient with periodotal disease by administering 3-[1-(4-chlorolbenzyl)-3-t-butyl-thio-t-isopropylindol-2-yl]-2,2dimethylpr opanoic acid.
    Type: Grant
    Filed: December 27, 1996
    Date of Patent: May 9, 2000
    Assignee: Board of Regents, The University of Texas System
    Inventors: Lynda F. Bonewald, G.R. Mundy, Wolf E. Gallwitz
  • Patent number: 6008259
    Abstract: Described is the use of microbicidal phenolic compounds in combination with glutaraldehyde for the preparation of disinfectants which are suitable for the disinfection of surfaces and instruments, but also of parts of the body (for example hands) in hospitals and doctors' surgeries.
    Type: Grant
    Filed: April 17, 1997
    Date of Patent: December 28, 1999
    Assignee: Bayer Aktiengesellschaft
    Inventors: Otto Exner, Manfred Hoffmann
  • Patent number: 6008260
    Abstract: A composition and method of cancer chemoprevention is disclosed. The composition and method utilize resveratrol as a cancer chemopreventative agent in mammals, including humans.
    Type: Grant
    Filed: January 9, 1998
    Date of Patent: December 28, 1999
    Assignee: Pharmascience
    Inventors: John M. Pezzuto, Richard C. Moon, Mei-Shiang Jang
  • Patent number: 5998487
    Abstract: An antibacterial, anti-inflammatory compound for use in oral products, of the formulae: ##STR1## Wherein: R.sub.1 and R.sub.2 are straight chain or branched alkyl substituents or cycloalkyls with one or more alkyl substituents.
    Type: Grant
    Filed: April 8, 1998
    Date of Patent: December 7, 1999
    Assignee: Colgate-Palmolive Company
    Inventors: John C. Brahms, Dale S. Scherl, Susan Herles, Stuart Shapiro, Abdul Gaffar
  • Patent number: 5994410
    Abstract: A method of treating a free radical-related medical condition. The method includes the step of administering to a subject in need of such treatment an effective amount of a compound of the formulaF(--X).sub.mwhereinF is a fullerene core; each X is independently OH, (CH.sub.2).sub.n --SO.sub.3 H, or a metal salt of (CH.sub.2).sub.n --SO.sub.3.sup.- in which each n is independently 2-50; and m is 2-40.
    Type: Grant
    Filed: July 15, 1997
    Date of Patent: November 30, 1999
    Assignee: National Science Council
    Inventors: Long Y. Chiang, Yih-Loong Lai, Ming-Cheng Tsai, Yuan-Teh Lee, Huei-Chen Huang, Ming-Kuen Lai, Fong-Jou Lu
  • Patent number: 5840765
    Abstract: A method of removal or retardation of growth of hair on the human body by application of phenol, a phenol derivative or a combination of at least two from the group of phenol and phenol derivatives. The element or combination is in the form of a liquid or paste and is applied to the skin and thereafter removed by cleansing. Hair growth is thereafter retarded or eliminated.
    Type: Grant
    Filed: August 4, 1997
    Date of Patent: November 24, 1998
    Inventor: Ethel Miller
  • Patent number: 5770593
    Abstract: The present invention provides a pharmaceutical combination preparation, wherein it contains at least two active materials, the first active material being an inhibitor of protein kinase C and the other active material having an anti-neoplastic action, as well as pharmacologically acceptable carriers and adjuvants.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: June 23, 1998
    Assignee: Boehringer Mannheim GmbH
    Inventors: Hans Hermann Grunicke, Dieter Herrmann, Johann Hofmann, Elmar Bosies
  • Patent number: 5723500
    Abstract: An oral antiplaque composition and treatment of teeth therewith wherein the essential antiplaque agent is a substantially water insoluble noncationic antibacterial phenol containing, relative to the hydroxyl group, an alkyl or cycloalkyl group, preferably tert.-butyl (t-butyl), in 2-position, and substituents in one or both of the 4- and 5-positions, one of which may be phenyl or 2', 3' and/or 4' substituted alkyl or cycloalkyl phenyl, preferably 4'-t-butyl phenyl or a phenanthrene containing a hydroxyl substituent in the 2- or 3-position and alkyl or cycloalkyl, preferably t-butyl, substituents in the other of the 2- and 3-positions and in at least one of the other rings. Novel antibacterial alkylated phenols are also described.
    Type: Grant
    Filed: May 17, 1996
    Date of Patent: March 3, 1998
    Assignee: Colgate-Palmolive Company
    Inventors: Orum D. Stringer, John C. Brahms, Malathy Subramanian, Ernest E. Kelly
  • Patent number: 5696170
    Abstract: Described is the use of microbicidal phenolic compounds in combination with glutaraldehyde for the preparation of disinfectants which are suitable for the disinfection of surfaces and instruments, but also of parts of the body, in hospitals and doctors' surgeries.
    Type: Grant
    Filed: November 21, 1995
    Date of Patent: December 9, 1997
    Assignee: Bayer Aktiengesellschaft
    Inventors: Otto Exner, Manfred Hoffmann
  • Patent number: 5663207
    Abstract: Gem-Dichlorocyclopropanes (Analog II derivatives) which demonstrate antiproliferative activity toward MCF-7 cells, in vitro and are generally not reversed by estradiol or having intrinsic estrogenicity (except the hydroxyphenyl derivative Compound 30). In general the cyclopropane compounds have the formula: ##STR1## or any pharmaceutically acceptable salt thereof. X is selected from a group consisting of hydrogen and halogen atoms. The group R.sub.1 may he a hydrogen atom, an alkyl group, an acyl group, or an arylalkyl group. The group R.sub.2 may be a hydrogen atom, an unsubstituted aryl group or a substituted aryl group. The group R.sub.3 may be a hydrogen atom, an alkyl group, a cycloalkyl group, a substituted aryl group or an unsubstituted aryl group. The group R.sub.4 may be a hydrogen atom, an unsubstituted aryl group or a substituted aryl group. The R.sub.4 is absent when R.sub.
    Type: Grant
    Filed: January 20, 1995
    Date of Patent: September 2, 1997
    Assignee: Research Corporation Technologies
    Inventors: Robert A. Magarian, Joseph T. Pento, May T. Griffin
  • Patent number: 5658951
    Abstract: Diphenylcyclopropyl analogs in which one or more of the phenyl rings includes alkoxy substituents including a dialkylaminoalkoxy group, an unsubstituted piperazine alkoxy group, a substituted piperazine alkoxy group, an unsubstituted piperidine alkoxy group, and a substituted piperidine alkoxy group, and which may have one or two alkyl groups bonded to the cyclopropane. The compounds are useful as antiestrogens and anti-tumor agents.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 19, 1997
    Assignee: Research Corporation Technologies
    Inventors: Robert A. Magarian, Joseph T. Pento, Lynette Overacre
  • Patent number: 5658927
    Abstract: Diphenylcyclopropyl analogs in which one or more of the phenyl rings includes alkoxy substituents including a dialkylaminoalkoxy group, an unsubstituted piperazine alkoxy group, a substituted piperazine alkoxy group, an unsubstituted piperidine alkoxy group, and a substituted piperidine alkoxy group, and which may have one or two alkyl groups bonded to the cyclopropane. The compounds are useful as antiestrogens and anti-tumor agents.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 19, 1997
    Assignee: Research Corporation Technologies
    Inventors: Robert A. Magarian, Joseph T. Pento, Lynette Overacre
  • Patent number: 5658914
    Abstract: Diphenylcyclopropyl analogs in which one or more of the phenyl rings includes alkoxy substituents including a dialkylaminoalkoxy group, an unsubstituted piperazine alkoxy group, a substituted piperazine alkoxy group, an unsubstituted piperidine alkoxy group, and a substituted piperidine alkoxy group, and which may have one or two alkyl groups bonded to the cyclopropane. The compounds are useful as antiestrogens and anti-tumor agents.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 19, 1997
    Assignee: Research Corporation Technologies
    Inventors: Robert A. Magarian, Joseph T. Pento, Lynette Overacre
  • Patent number: 5652266
    Abstract: A cosmetic or dermatological composition containing a skin enhancing agent consisting essentially of a) at least one .alpha.-hydroxy acid, b) salicylic acid or esters thereof and c) at least one retinoid in a skin enhancing method.
    Type: Grant
    Filed: March 27, 1995
    Date of Patent: July 29, 1997
    Assignee: The Boots Company PLC
    Inventors: Carinne Bobier-Rival, Odile Fournier, Alain Fructus
  • Patent number: 5629350
    Abstract: Stable, concentrated aqueous suspensions of ortho-phenylphenol (OPP) which contribute minimal chemical oxygen demand and methods of preparing and using said suspensions in biocidal applications have been discovered. The formulations comprise from about 3 to about 70 weight percent of OPP suspended in about 30 to about 97 weight percent water in the presence of a suspending amount of a thixotrope that exhibits Ellis-Plastic behavior.
    Type: Grant
    Filed: March 20, 1996
    Date of Patent: May 13, 1997
    Assignee: The Dow Chemical Company
    Inventor: Charles D. Gartner
  • Patent number: 5591435
    Abstract: Preparations from aromatic plants that are insecticidal or are insect behaviorally active, are used to control the development of insect populations. Leaves are milled or out drying to a small average particle size. Extracts and vapors may also be used. The resultant preparation, when contacted dry commodities or structures such as books or carpets, grain bins feed/flour mills, equipment, greenhouse or ornamental plants infested storage insects or insect infested perishable produce after harvest will reduce the insect population. In addition, soil may be fumigated the extracts.
    Type: Grant
    Filed: April 25, 1994
    Date of Patent: January 7, 1997
    Assignee: The Research and Development Institute, Inc.
    Inventors: Florence Vaccarello-Dunkel, David K. Weaver, Theodore W. Weaver, III
  • Patent number: 5585403
    Abstract: A sterilizing agent comprising:(A) a dichlorobenzene; and(B) a dialkyldimethylammonium halide represented by the formula ##STR1## wherein X is bromine or chlorine, and,R.sub.1 and R.sub.2 each independently represent an alkyl group.
    Type: Grant
    Filed: February 5, 1995
    Date of Patent: December 17, 1996
    Assignee: Tamura Seiyaku Kabushiki Kaisha
    Inventors: Reiji Seki, Ryoji Kamimura, Satoru Mitsubayashi
  • Patent number: 5578590
    Abstract: The present invention provides a method of inhibiting protein kinase C in a mammal having a tumor system which contains protein kinase C, which mammal is undergoing cytostatic therapy. The method comprises administering to the mammal a protein kinase C inhibitor.
    Type: Grant
    Filed: October 7, 1994
    Date of Patent: November 26, 1996
    Assignee: Boehringer Mannheim GmbH
    Inventors: Hans H. Grunicke, Dieter Herrmann, Johann Hofmann, Elmar Bosies
  • Patent number: 5397802
    Abstract: Gem-Dichlorocyclopropanes (Analog II derivatives) which demonstrate antiproliferative activity toward MCF-7 cells, in vitro and are generally not reversed by estradiol or having intrinsic estrogenicity (except the hydroxyphenyl derivative Compound 30). In general the cyclopropane compounds have the formula: ##STR1## or any pharmaceutically acceptable salt thereof. X is selected from a group consisting of hydrogen and halogen atoms. The group R.sub.1 may be a hydrogen atom, an alkyl group, an acyl group, or an arylalkyl group. The group R.sub.2 may be a hydrogen atom, an unsubstituted aryl group or a substituted aryl group. The group R.sub.3 may be a hydrogen atom, an alkyl group, a cycloalkyl group, a substituted aryl group or an unsubstituted aryl group. The group R.sub.4 may be a hydrogen atom, an unsubstituted aryl group or a substituted aryl group. The R.sub.4 is absent when R.sub.
    Type: Grant
    Filed: February 22, 1993
    Date of Patent: March 14, 1995
    Assignee: Research Corporation Technologies, Inc.
    Inventors: Robert A. Magarian, Joseph T. Pento, May T. Griffin
  • Patent number: 5190932
    Abstract: The invention relates to the use of water-soluble polymers containing chemically bonded tertiary and/or quaternary ammonium groups as auxiliaries for formulating microbicides, the microbicide formulations prepared using these water-soluble polymers and the use of these formulations for preserving industrial materials.
    Type: Grant
    Filed: July 11, 1990
    Date of Patent: March 2, 1993
    Assignee: Bayer Aktiengesellschaft
    Inventors: Rolf Dhein, Lothar Backer, Otto Exner, Walter Radt, Ingrid Radt, Christian Radt, Hans G. Schmitt
  • Patent number: 5154920
    Abstract: Liquid disinfectant compositions are disclosed which can be used to surface-coat substrates with polymeric films which are adherent, water-resistant and which can impart prolonged germicidal properties to the treated surfaces.
    Type: Grant
    Filed: October 21, 1987
    Date of Patent: October 13, 1992
    Assignee: Ecolab Inc.
    Inventors: Daniel J. Flesher, Robert T. Hall, Richard C. Chromecek, Michael C. Braun
  • Patent number: 5030659
    Abstract: Liquid, aqueous disinfectant preparations containing a combination of(a) at least one microbicidal quaternary ammonium compound(b) at least one microbicidal biguanide compound and(c) at least one microbicidal phenolic compound,components (a) and (b) being present in a ratio by weight a:b of (16 - 2); 1 while components (a) and (c) are present in a ratio by weight a:c of (16 - 2):1.
    Type: Grant
    Filed: February 8, 1990
    Date of Patent: July 9, 1991
    Assignee: Henkel Kommanditgesellschaft auf Aktien
    Inventors: Klaus Bansemir, Karlheinz Disch, Klaus Hachmann
  • Patent number: 5021448
    Abstract: A method of reducing serum uric acid and/or increasing renal clearance of uric acid in a mammal in need thereof comprising administering to such mammal a uricosuric effective amount of a thromboxane synthetase inhibitor, a thromboxane receptor antagonist, or both in a combined uricosuric effective amount is disclosed. Compositions having one or more of the foregoing in combination with one or more known uricosurics are also set forth.
    Type: Grant
    Filed: February 22, 1990
    Date of Patent: June 4, 1991
    Assignee: Ciba-Geigy Corporation
    Inventors: Anthony J. Piraino, Steven D. Saris
  • Patent number: 4898883
    Abstract: The present invention relates to 1-substituted derivatives of 4-methoxy-2,3,6-trimethylbenzene which are useful in cosmetic or pharmaceutical preparations for use in the treamtnet of dermatological complaints connected with a keratinisation disorder, dermatological complaints having an inflammatory and/or immuno-alleric component or ophthalmological complaints.
    Type: Grant
    Filed: July 21, 1987
    Date of Patent: February 6, 1990
    Assignee: L'Oreal
    Inventors: Gerard Lang, Serge Forestier, Alain Lagrange, Braham Shroot
  • Patent number: 4895727
    Abstract: This invention is a method of inducing a reservoir effect in skin and mucous membranes so as to enhance penetration and retention and reduce transdermal flux of topically applied therapeutic and cosmetic pharmacologically active agents. The invention also relates to topical treatment methods involving such reservior effect enhancers, and to pharmaceutical compositions containing them.
    Type: Grant
    Filed: May 3, 1985
    Date of Patent: January 23, 1990
    Assignee: Chemex Pharmaceuticals, Inc.
    Inventor: Larry M. Allen
  • Patent number: 4880637
    Abstract: The present invention provides new compositions comprising catecholic butanes and ionic zinc. The invention also relates to pharmacologically active compositions comprising said new compositions, which are useful in the treatment of benign, premalignant and malignant solid tumors, especially those of the skin. The ionic zinc may be in the form of a zinc salt, and the preferred catecholic butane is nordihydroguaiaretic acid.
    Type: Grant
    Filed: October 28, 1986
    Date of Patent: November 14, 1989
    Assignee: Chemex Pharmaceuticals, Inc.
    Inventor: Russell T. Jordan
  • Patent number: 4675327
    Abstract: Embalming preparations, which are far less noxious than previously known compositions, comprise a combination of a disinfectant and a plant growth regulating compound. The compositions achieve anti-microbial potency at concentrations of these ingredients far lower than the concentration levels of disinfectants found in known embalming preparations.
    Type: Grant
    Filed: April 8, 1983
    Date of Patent: June 23, 1987
    Assignee: The Dodge Chemical Company
    Inventor: Jerome F. Fredrick
  • Patent number: 4672395
    Abstract: The combination of an optical information recording and reproducing medium and a container for storing said optical information recording and reproducing medium, at least one of said optical information recording and reproducing medium and said container comprising a fungicide wherein said fungicide is in a layer selected from the group consisting of a layer comprising fine metal particles dispersed in a hydrophilic colloid dispersion medium; a layer comprising a metal or an alloy formed by a vacuum evaporation method or a sputtering method; and a layer comprising a coloring substance or consisting essentially of a polymeric substance. The invention also provides said medium when it contains a fungicide and a method for making the claimed combination and components thereof.
    Type: Grant
    Filed: September 30, 1985
    Date of Patent: June 9, 1987
    Assignee: Konishiroku Photo Industry Co., Ltd.
    Inventors: Kazuo Arai, Shinichi Nishi, Taxey Satoh, Yasushi Kawaguchi, Kiyomitsu Mine
  • Patent number: 4654374
    Abstract: The invention is an improved disinfectant and sterilant in a chemical form. The disinfectant and sterilant formulation is based upon glutaraldehyde which must be in acidic form. The normal pH range for the disinfectant and sterilant is 3.0-3.5, however, under controlled circumstances the range may be 2.5-7.0; as the disinfectant and sterilant must be acidic, it cannot be over pH 7.0. In use as a disinfectant by immersion, the items or materials remain immersed for up to ten minutes. As a sterilant, the immersion is between six and ten hours. The disinfectant and sterilant consists of a plurality of chemicals mixed with the glutaraldehyde as a solution.
    Type: Grant
    Filed: March 8, 1985
    Date of Patent: March 31, 1987
    Inventor: Howard Martin
  • Patent number: 4593040
    Abstract: The invention relates to synergistically active mixtures for the control of phytopathogenic fungi and bacteria comprising antimicrobially effective derivatives of a phenol of the general formula ##STR1## R.sub.1, R.sub.2, R.sub.5 and R.sub.6 represent hydrogen (for R.sub.5 and R.sub.6 only), bromine, chlorine or alkyl with up to 5 C-atoms, R.sub.3 represents hydrogen, sodium, potassium, calcium, barium or ammonium*, magnesium, bismuth, tin, zinc or copper, furthermore R.sub.1, R.sub.2 and R.sub.3 may be interchangeably positioned in the ortho position as well as in the para position, and using fungicides.Benzimidazole fungicides or dithiocarbamates are predominantly used preferably on potato tubers with carbendazim and thiabendazole as mixing components.
    Type: Grant
    Filed: August 17, 1982
    Date of Patent: June 3, 1986
    Assignee: VEB Berlin-Chemie
    Inventors: Lothar Adam, Ursula Albrecht, Ulrich Burth, Axel Kramer, Sieghard Luck, Rainer Muller, Lothar Neeb, Hubert Rattba, Wolfgang Weuffen
  • Patent number: 4525362
    Abstract: Selected substituted phenols may be usefully employed as mosquito development inhibitors.
    Type: Grant
    Filed: March 1, 1984
    Date of Patent: June 25, 1985
    Inventors: Sol J. Barer, Henry A. Terwedow, Jr.